Drugs that contain Levetiracetam

1. Drug name - ELEPSIA XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8535717 TRIPOINT Pharmaceutical composition Feb, 2026

(3 years from now)

US8425938 TRIPOINT Pharmaceutical composition Feb, 2026

(3 years from now)

US8163306 TRIPOINT Oral drug delivery system Sep, 2027

(4 years from now)

US8431156 TRIPOINT Pharmaceutical composition Oct, 2027

(5 years from now)

US8470367 TRIPOINT Oral drug delivery system Oct, 2027

(5 years from now)

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
1GM TABLET, EXTENDED RELEASE;ORAL Prescription
1.5GM TABLET, EXTENDED RELEASE;ORAL Prescription

2. Drug name - KEPPRA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8802142 UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation Jun, 2031

(8 years from now)

US8802142

(Pediatric)

UCB INC Pharmaceutical compositions comprising levetiracetam and process for their preparation Dec, 2031

(9 years from now)

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
1GM TABLET;ORAL Prescription
250MG TABLET;ORAL Prescription
500MG TABLET;ORAL Prescription
750MG TABLET;ORAL Prescription

3. Drug name - KEPPRA XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7858122 UCB INC Extended release formulation of levetiracetam Sep, 2028

(5 years from now)

Treatment: NA

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
500MG TABLET, EXTENDED RELEASE;ORAL Prescription
750MG TABLET, EXTENDED RELEASE;ORAL Prescription

4. Drug name - SPRITAM

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9339489 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam Mar, 2034

(11 years from now)

US9669009 APRECIA PHARMS Rapid disperse dosage form containing levetiracetam Mar, 2034

(11 years from now)

US11160786 APRECIA PHARMS Rapid disperse dosage form Mar, 2034

(11 years from now)

Treatment: Method of administering levetiracetam; Method of administering levetiracetam under fasted conditions; method of administering levetiracetam; method of administering levetiracetam under fed conditions

Dosage: TABLET, FOR SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
1GM TABLET, FOR SUSPENSION;ORAL Prescription
250MG TABLET, FOR SUSPENSION;ORAL Prescription
500MG TABLET, FOR SUSPENSION;ORAL Prescription
750MG TABLET, FOR SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.